COMPANY INFO
ZBiotics, officially founded in 2016 by Zack Abbott and Stephen Lamb, is a biotechnology research company headquartered in San Francisco, California, with approximately 46 employees. The company pioneers genetically engineered probiotics designed to enhance the body's ability to break down harmful byproducts of alcohol and convert sugar into fiber, aiming to help people live healthier, happier lives through innovative microbial engineering. Their website is https://zbiotics.com and they operate primarily in the biotechnology, health & nutrition products, and beverages industries.
ZBiotics, founded in 2016 by Zack Abbott and Stephen Lamb, is a biotechnology company based in San Francisco, California. Specializing in the intersection of biotechnology, health & nutrition products, and beverages, ZBiotics has made a name for itself by pioneering genetically engineered probiotics. Their flagship products are designed to enhance the body's ability to break down harmful byproducts of alcohol and convert sugar into fiber, with the ultimate goal of helping people live healthier, happier lives through innovative microbial engineering.
ZBiotics funding history showcases a growth-oriented approach, focusing on research and development, product innovation, and expanding market reach. To date, the company has raised a total of $40.3 million over five funding rounds. Their investment strategy emphasizes bringing new use cases for engineered probiotics to market, scaling operations, and delivering consumer health solutions. Milestones include a strong initial backing from influential investors such as Y Combinator and BABEL Ventures and a successful Series A with participation from growth-focused venture capital firms.
This round was aimed at expanding ZBiotics' retail footprint and accelerating the development of engineered probiotics for new health applications including gut health, sleep, vaginal health, and athletic performance.
Funds from this round were allocated to product development and further market expansion, supporting ZBiotics' evolution as a biotech leader in consumer health.
Focused on enhancing product development, this early Series A round provided capital for scaling science, manufacturing, and market reach.
Led by Y Combinator, this seed round was used to launch ZBiotics' initial commercial operations and prepare for market entry.
Backed by BABEL Ventures, the funds from this seed round helped launch ZBiotics' foundational R&D and company formation.
Springtide is a venture capital firm specializing in early and growth-stage biotech companies. As a lead investor in ZBiotics' latest Series A round, Springtide has been instrumental in fueling the company's expansion into new markets and health applications.
Seamless also participated in ZBiotics' most recent funding, providing not just capital but also industry expertise to support market scaling and commercialization strategies.
Oyster Ventures led the 2020 Series A round, offering crucial early-stage backing that allowed ZBiotics to accelerate its research and bring products closer to commercialization.
Renowned for its seed investments in high-potential startups, Y Combinator's support in the 2018 seed round provided capital and mentorship, launching ZBiotics onto the global stage.
As a lead investor in the earliest seed round, BABEL Ventures enabled the foundational development of ZBiotics' technology and helped validate its original business model.
FJ Labs is known for investing in disruptive technology ventures. Their participation in ZBiotics funding rounds reflects confidence in the company's innovation and growth potential.
Able Partners backs innovative consumer health companies, and its involvement signaled strong support for ZBiotics’ mission and long-term strategy.
Access Capital was one of the lead investors in the company's latest Series A round, contributing to ZBiotics investment surge for new product expansion and retail scaling.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching ZBiotics funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.